Showing 141-150 of 10098 results for "".
Transgender Inclusion in Dermatology: Creating a Welcoming, Safe, Affirming Practice for All
https://practicaldermatology.com/series/the-practical-dermatology-podcast/transgender-inclusion-in-dermatology-creating-a-welcoming-safe-affirming-practice-for-all/18197/Klint Peebles, MD, a Washington, DC board-certified dermatologist with expertise in working with sexual and gender-diverse patients, discusses steps that can be taken to make patients more comfortable in healthcare settings.SCALE 2024: Dr. Hilary Baldwin’s Tips and Tricks for Treating Keloids
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-hilary-baldwins-tips-and-tricks-for-treating-keloids/26366/Hilary E. Baldwin, MD, discusses best practices for the treatment of keloids at Music City SCALE.DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approves-humira-biosimilar-study-examines-trifarotene-acne-lesions/24513/In this episode of DermwireTV, the FDA approves a high-concentration Humira biosimilar; a study finds trifarotene combined with a skincare regimen was effective for acne-induced hyperpigmentation; the FDA accepts Dermavant's NDA for Vtama cream for AD; and the PA Perspective series addresses buildinTop Tips for Increasing Social Media Engagement
https://practicaldermatology.com/topics/practice-management/top-tips-for-increasing-social-media-engagement/23709/It takes time to grow your base, but if you know your audience and strategize, you can see gains.DermWire TV: Adbry Approved; Syringoma Option; Confusion over Vaccines and Injectables
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-adbry-approved-syringoma-option-confusion-over-vaccines-and-injectables/20041/Adbry (tralokinumab) from Leo Pharma is the newest biologic approved for moderate to severe atopic dermatitis in adults and is the first IL-13 blocker approved in the US. Pulse Bioscience’s nano-pulse stimulation (NPS) technology shows potential for the treatment of syringoma in a feasibility studyDermWireTV: Cosentyx for Kids; Anifrolumab for SLE, Tremfya in PsA at EULAR
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-for-kids-anifrolumab-for-sle-tremfya-in-psa-at-eular/19948/FDA has approved Cosentyx (secukinumab) from Novartis for patients as young as six years old. The 2nd Annual San Diego Dermatology Symposium kicks off as a live Virtual Experience next Friday. A post-hoc analysis of pooled data from the TULIP Phase 3 clinical trials shows that anifrolumab improvesMentorship Matters: Set the Pace for Long-term Success
https://practicaldermatology.com/topics/practice-management/mentorship-matters-set-the-pace-for-long-term-success/23406/Mentoring is one free strategy to building a better team. Here’s how a small but busy practice builds and develops its team and community through mentoring.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReInjection Tip: Start Superiorly
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injection-tip-start-superiorly/18358/When using fillers, start superiorly, says Cheryl Burgess, MD. The approach may optimize lift and allow patients to achieve correction with less filler than originally estimated, she says.Surgical Tips from a Mohs Surgeon
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgical-tips-from-a-mohs-surgeon/18694/There are many options for healing defects or treating scars after skin cancer excisions. Joel L. Cohen, MD shares tips for success.